Schematic illustration of high-speed AFM observation (left) and consecutive high-speed AFM images of Afamin (right). Afamin consists of a large part (red) and a small part (light blue), and was ...
When Milenko Cicmil, PhD, first heard about the technology underlying Tasca Therapeutics, a newly-minted small molecular inhibitor company, he was intrigued. The privately-held company, which launched ...